Here’s whether BioMarin Pharmaceuticals Inc (BMRN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: RSI 45 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.90% over 10 days); 3-month momentum negative (-13.6%); rising volume on a downtrend (distribution, 1.23x avg). Currently 18.4% off its 52-week high. Score: -4/7.
BMRN is trading below its 200-day MA ($55.91) — a key warning sign the longer-term trend is under pressure. An RSI of 45.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -6.8% compares to +27.9% for SPY (trailed the market by 34.6%).
$10,000 invested 1 year ago→ $9,324 today
vs. S&P 500 (SPY) — same period trailed market by 34.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($55.91)
✗Above 50-day MA ($54.46)
✓RSI(14) neutral zone (30–70) — currently 45.4
✗Positive return (-6.8%)
!Within 10% of period high (−18.4%)
Period Range $54.09
$49.26$66.28
RSI (14) 45.4
0 · OversoldOverbought · 100
Key Metrics
Price$54.09
Period Return-6.8%
Period High$66.28
Period Low$49.26
Drawdown−18.4%
MA-50$54.46
MA-200$55.91
RSI (14)45.4
Avg Volume (30d)2.0M
vs. SPYtrailed by 34.6%
Return Rank#792 of 1236
Trend Signals
Price is below the 200-day moving average ($55.91)